Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Global Flash Chromatography Market by Sales Type (Consumables and Systems), by Technique Type (Reverse Phase, Ion Exchange, Size Exclusion, Chiral Separation, and Others), by Component Type (Columns and Detectors), by End-Use Industry Type (Pharmaceutical
... strategy formulation based on the opportunities present in the market. The Global Flash Chromatography Market: Highlights The global flash chromatography market was valued at US$ 210.7 million in 2016 and is projected to grow at ... Read More
-
Laos Pharmaceuticals & Healthcare Q3 2018
... to act as key drivers of market growth. Meanwhile, the government will remain committed to improving the regulatoryand business environment. That said, the small domestic drug market, combined with low spending per capita on medicine ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q3 2018
... impact on the healthcare andpharmaceutical opportunities in the country. Increased public sector funding should significantly reduce the over-reliance on out-of-pocket payments, footed by the, generally speaking, low-income population. The country's demographic profile also doesprovide commercial ... Read More
-
Antiemetics: Technologies and Global Markets
... drugs, and challenges to market growth. The report also examines disease burden, regulatory environment, novel technologies, and market projections to 2023. Antiemetic drug market drivers, trends and potential regional market opportunities are also covered in ... Read More
-
Nicaragua Pharmaceuticals & Healthcare Q3 2018
... has seen attacks on health facilities and their staff across the nation, will provide headwinds for stakeholders inthe country in 2018. Nevertheless, we retain our view that the market will report strong performance from 2019 ... Read More
-
Austria Pharmaceuticals & Healthcare Q3 2018
... incomparison to its EU partners. However, like its eurozone neighbours, we believe Austria's pharmaceutical spending will be subduedover the medium term, as states scramble to contain rising pharmaceutical expenditure in line with increasing healthcare demands. Read More
-
Hungary Pharmaceuticals & Healthcare Q3 2018
... its regional peers in the coming years. Whilean ageing population will support long-term market growth, significant healthcare funding issues remain prominent, leading tomedicine shortages and growing waiting lists, while also placing pressure on pharmaceutical expenditure. Read More
-
Botswana Pharmaceuticals & Healthcare Q3 2018
... by a weakregulatory environment, small pensionable population and a highly ruralised community. Generic medicines will continue todominate the market, with patented drugmakers choosing to operate in larger markets in the region such as South African. Read More
-
Costa Rica Pharmaceuticals & Healthcare Q3 2018
... and development opportunities tomultinationals, based on factors such as continuous improvement in healthcare infrastructure and government commitment toupholding an attractive business environment. Additionally, the demand for innovative medicines will still need to be met through ... Read More
-
Gabon Pharmaceuticals & Healthcare Q3 2018
... diseases will remain significant, we expect the increasein the incidence of non-communicable diseases to be the key driver of longer-term pharmaceutical market's trajectory. Commercialopportunities will mostly remain in the generic segment, given the rising role ... Read More
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Marijuana Stores
... The multibillion-dollar global industry is experiencing strong growth, though the newness of the market and variance in regulation across geographies creates major barriers to entry. The industry includes medical marijuana dispensaries and stores that sell ... Read More
-
LIQUID BIOPSY MARKETS by Cancer Type by Diagnosis, Monitoring & Recurrence Testing. 2019-2023 w. Historical Data Including Screening Market Potential Size with Executive and Consultant Guides
... in vitro blood testing to identify cancer DNA. The technology creates new markets for cancer screening tests. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024
... is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction ... Read More
-
Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic SWOT Analysis Review
... to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling ... Read More
-
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Imprimis Pharmaceuticals Inc (IMMY) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Magellan Health Inc (MGLN) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis Review
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More
-
Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Pipeline Review, H2 2018
... Raf - Pipeline Review, H2 2018'; Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) pipeline Target constitutes close to 5 molecules. Out of which approximately ... Read More
-
Tourette Syndrome - Pipeline Review, H2 2018
... System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or ... Read More
-
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H2 2018
... Summary Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to ... Read More
